San Mateo, CA, United States of America

David T Jackson

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David T Jackson. Retrieved from https://idiyas.com/inventor/david-t-jackson-bqkc4zvo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of David T. Jackson: A Pioneer in Serine Protease Variants

Introduction: David T. Jackson is an accomplished inventor based in San Mateo, California. With a keen focus on biochemistry, he has made significant contributions to the field through his innovative work on serine protease variants. His inventions pave the way for advancements in peptide ligase activity, demonstrating the impact of his research on both the scientific community and the industry.

Latest Patents: David holds a notable patent for "Serine protease variants having peptide ligase activity." This invention relates to creating serine protease variants derived from precursor serine proteases through recombinant and/or chemical methods. These variants exhibit improved peptide ligase activity, which is crucial for forming ligation products. Furthermore, the patent encompasses novel ligation substrates that, when combined with the serine protease variants and a second substrate, are capable of producing a desired ligation product. The patent also details methods for generating these ligation products, showcasing Jackson's innovative approach to biochemistry.

Career Highlights: Currently, David T. Jackson is affiliated with Genentech, Inc., where he continues to push the boundaries of scientific research. His work at Genentech has not only contributed to the company's innovative portfolio but also positioned him as a key player in the field of biotechnology. His patent signifies a milestone in understanding serine protease functionality and its applications in various medical and industrial processes.

Collaborations: Throughout his career, David has collaborated with renowned professionals, including Lars B. Abrahmsen and John P. Burnier. These collaborations have enhanced his research and fostered a rich exchange of knowledge and expertise, allowing for more comprehensive approaches to solving complex scientific challenges.

Conclusion: David T. Jackson's contributions to the field of biochemical innovations through his patent on serine protease variants reflect his dedication and expertise as an inventor. His work at Genentech, Inc., coupled with fruitful collaborations, underscores his role in advancing biotechnology and its applications. Jackon's innovative research is a testament to the transformative power of invention in the scientific landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…